Muscle Function, Central Nervous System Sensitization, and Pain Profiling in Patients With Subacromial Pain (SAP-CNSS).
The Subacromial Shoulder Pain and Central Nervous System Sensitization Trial (SAP-CNSS):Central Nervous System Sensitization, Muscle Function, and Pain Profiling in Patients With Subacromial Pain and in Healthy Controls.
1 other identifier
observational
72
1 country
1
Brief Summary
In this case-control study, the investigators compare shoulder muscle function, pain, and central nervous system sensitization in patients with Subacromial Pain (SAP) to that in healthy controls. The investigators also examine if a relationship exists between shoulder symptom duration and central sensitization, shoulder muscle function and shoulder pain distribution in patients with SAP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 12, 2017
CompletedFirst Posted
Study publicly available on registry
October 31, 2017
CompletedStudy Start
First participant enrolled
November 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2020
CompletedFebruary 21, 2019
February 1, 2019
2.7 years
October 12, 2017
February 20, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Maximal Voluntary Strength.
Unit of Measure: Nm/Kg.
Baseline assessment, no follow-up (cross-sectional study).
Submaximal Voluntary Force Steadiness
Unit of Measure: Nm/Kg.
Baseline assessment, no follow-up (cross-sectional study).
Maximal EMG
Unit of Measure: mV/s. Will be recorded during the measurement of Maximal Voluntary Strength.
Baseline assessment, no follow-up (cross-sectional study).
Submaximal EMG.
Unit of Measure: mV/s. Will be recorded during the Measurement of Force Steadiness.
Baseline assessment, no follow-up (cross-sectional study).
Central Nervous System Sensitization - Manual Algometry.
Unit of Measure: kPa/s
Baseline assessment, no follow-up (cross-sectional study).
Central Nervous System Sensitization - Cuff Algometry.
Unit of Measure: kPa/s.
Baseline assessment, no follow-up (cross-sectional study).
Patient Reported Outcome - Pain Mapping.
Subject will draw their pain as accurately as possible on a high resolution 3D body schema. Area of Pain is quantified as total number of pixels, and will be expressed as percentage of body area.
Baseline assessment, no follow-up (cross-sectional study).
Patient Reported Outcome - Shoulder Pain And Disability Index (SPADI).
Questionnaire contains 13 items with a possible score from 0-100 (0=no disability).
Baseline assessment, no follow-up (cross-sectional study).
Patient Reported Outcome - Pain Catastrophizing Scale (PCS).
Questionnaire contains 13 items with a possible score 0-52. Higher score indicates higher level of pain catastrophizing.
Baseline assessment, no follow-up (cross-sectional study).
Study Arms (2)
Patients with SAP
Healthy Controls
Eligibility Criteria
Subacromial Pain.
You may qualify if:
- Have had SAP during the last two weeks or more.
- Have positive results from minimum 3 out of 5 clinical tests.
- Have experienced pain ranking 4 or above on the VRS scale within the last 7 days.
- Are able to speak and understand Danish.
- Have given informed consent to participate in the study after they have fully understood the content of the study.
You may not qualify if:
- Have acquired traumatic shoulder injury, and this is onset/cause for current shoulder pain, e.g. fall on shoulder.
- Have received a corticosteroid injection within the last six weeks.
- Report having had a shoulder fracture within 6 months.
- Report having had surgery on the affected shoulder.
- Report having radiologically verified glenohumeral osteoarthritis.
- Have a luxation or sub-luxation of the glenohumeral or the acromioclavicular joint, clinically suspected labrum lesion, clinically suspected complete traumatic tear of the rotator cuff, frozen shoulder, suspected competing diagnoses (i.e. rheumatoid arthritis, cancer, neurological disorders, and fibromyalgia).
- Have a history of diagnosed major psychiatric disorder.
- Have a history of illicit drug use; be currently abusing alcohol or currently withdrawing from alcohol abuse.
- Have a history of heart disease.
- Are pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hvidovre University Hospital
Hvidovre, Sealand, 2650, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Thomas Bandholm, PhD
Professor, Head of Research, PMR-C.
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc, PhD
Study Record Dates
First Submitted
October 12, 2017
First Posted
October 31, 2017
Study Start
November 13, 2017
Primary Completion
July 31, 2020
Study Completion
July 31, 2020
Last Updated
February 21, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will share
We intend to make the data set - containing de-identified individual-patient data - publically available no later than 6 months after publication, consistent with the recent proposal from the International Committee of Medical Journal Editors (ICMJE), if it complies with national regulations, e.g. the Danish Data Protection Agency.